Error-prone replication of West Nile virus caused by ribavirin
- PMID: 15919121
- DOI: 10.1016/j.antiviral.2005.04.002
Error-prone replication of West Nile virus caused by ribavirin
Abstract
Ribavirin has been reported to cause error-prone replication and viral extinction in RNA viruses. The antiviral activity of ribavirin against West Nile virus (WNV) was evaluated in various cell lines to select a model in which mutagenic effects could be studied. The antiviral activity was greatest in HeLa cells as compared to CV-1, L929, Vero, or MA-104 cells. WNV was also passaged sequentially in cell monolayers treated with ribavirin to determine whether cumulative mutations could lead to viral extinction in these cell lines. The virus was abrogated in HeLa cells after 4 passages, while high viral titers persisted after many passages in other cells. A molecular clone of WNV was propagated in HeLa cells treated with 15 microg/mL ribavirin, and sequencing of viral genome segments revealed significant increases in transition mutations, demonstrating that ribavirin induced error-prone replication. The relative infectivity of viral RNA synthesized in the presence of ribavirin was shown to be reduced compared with untreated controls. These data support the hypothesis that error catastrophe is one of the modes of action for ribavirin against WNV.
Similar articles
-
In vitro efficacy of ribavirin against canine distemper virus.Antiviral Res. 2008 Feb;77(2):108-13. doi: 10.1016/j.antiviral.2007.09.004. Epub 2007 Oct 8. Antiviral Res. 2008. PMID: 17949825
-
The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.Mol Pharmacol. 2006 Apr;69(4):1461-7. doi: 10.1124/mol.105.020057. Epub 2006 Jan 18. Mol Pharmacol. 2006. PMID: 16421290
-
Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.Virus Res. 2005 Feb;107(2):173-81. doi: 10.1016/j.virusres.2004.11.007. Virus Res. 2005. PMID: 15649563 Review.
-
Genetic systems of West Nile virus and their potential applications.Curr Opin Investig Drugs. 2003 Aug;4(8):959-65. Curr Opin Investig Drugs. 2003. PMID: 14508880 Review.
-
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.J Infect Dis. 2000 Oct;182(4):1214-7. doi: 10.1086/315847. Epub 2000 Aug 22. J Infect Dis. 2000. PMID: 10979920
Cited by
-
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0131522. doi: 10.1128/aac.01315-22. Epub 2023 Jan 5. Antimicrob Agents Chemother. 2023. PMID: 36602354 Free PMC article.
-
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2.Antiviral Res. 2023 Feb;210:105501. doi: 10.1016/j.antiviral.2022.105501. Epub 2022 Dec 22. Antiviral Res. 2023. PMID: 36567022 Free PMC article. Review.
-
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity.Viruses. 2022 Apr 18;14(4):841. doi: 10.3390/v14040841. Viruses. 2022. PMID: 35458571 Free PMC article. Review.
-
An epigenetic 'extreme makeover': the methylation of flaviviral RNA (and beyond).RNA Biol. 2021 May;18(5):696-708. doi: 10.1080/15476286.2020.1868150. Epub 2021 Jan 18. RNA Biol. 2021. PMID: 33356825 Free PMC article. Review.
-
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.Pathogens. 2020 Apr 26;9(5):320. doi: 10.3390/pathogens9050320. Pathogens. 2020. PMID: 32357471 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical